NIH-funded research R21 grant

A new test for detecting gonorrhea using advanced technology.

Official title: Ultrasensitive Point of Care Antigen Test for Detection of Neisseria Gonorrhoeae Using Plasmonic Flours

Funded at Washington University · NIH-10891640 · Data updated 2026-11-12

This study is working on a quick and easy test for gonorrhea that can give accurate results right where you are, using urine samples, so it’s especially helpful for people in places where regular testing isn’t available.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 1, 2023
Project endJuly 31, 2026
Funding year2024
Award (this year)$201,208
NIH project number5R21AI178217-02
Project IDNIH-10891640 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who are suspected of having a gonorrhea infection and can provide urine samples for testing.

Less likely to help

Patients who have already been diagnosed and treated for gonorrhea may not benefit from this research.

What this research studies

This research aims to develop a highly sensitive and rapid antigen test for Neisseria gonorrhoeae, the bacteria responsible for gonorrhea. By utilizing innovative plasmonic-fluors technology, the test seeks to provide accurate results at the point-of-care, making it accessible even in resource-limited settings. The study will involve optimizing the test for urine samples and comparing its accuracy against the current gold standard tests. This approach could significantly improve the diagnosis of gonorrhea, especially in areas where traditional testing methods are not feasible.

Why it matters

Potential benefit: If successful, this research could lead to a more accurate and accessible method for diagnosing gonorrhea, improving patient outcomes and public health responses.

How similar studies have gone: Other research has shown promise in developing rapid diagnostic tests for sexually transmitted infections, but this specific approach using plasmonic-fluors is novel.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Gandra, Sumanth — Washington University
  • Study coordinator: Gandra, Sumanth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.